285 related articles for article (PubMed ID: 21461712)
41. In vitro expanded skeletal myogenic progenitors from pluripotent stem cell-derived teratomas have high engraftment capacity.
Xie N; Chu SN; Azzag K; Schultz CB; Peifer LN; Kyba M; Perlingeiro RCR; Chan SSK
Stem Cell Reports; 2021 Dec; 16(12):2900-2912. PubMed ID: 34798067
[TBL] [Abstract][Full Text] [Related]
42. Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors.
Kim J; Magli A; Chan SSK; Oliveira VKP; Wu J; Darabi R; Kyba M; Perlingeiro RCR
Stem Cell Reports; 2017 Jul; 9(1):12-22. PubMed ID: 28528701
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice.
Wu R; Li H; Zhai L; Zou X; Meng J; Zhong R; Li C; Wang H; Zhang Y; Zhu D
Nat Commun; 2015 Jul; 6():7713. PubMed ID: 26151913
[TBL] [Abstract][Full Text] [Related]
44. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells.
Mizuno Y; Chang H; Umeda K; Niwa A; Iwasa T; Awaya T; Fukada S; Yamamoto H; Yamanaka S; Nakahata T; Heike T
FASEB J; 2010 Jul; 24(7):2245-53. PubMed ID: 20181939
[TBL] [Abstract][Full Text] [Related]
45. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
46. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.
Rouger K; Larcher T; Dubreil L; Deschamps JY; Le Guiner C; Jouvion G; Delorme B; Lieubeau B; Carlus M; Fornasari B; Theret M; Orlando P; Ledevin M; Zuber C; Leroux I; Deleau S; Guigand L; Testault I; Le Rumeur E; Fiszman M; Chérel Y
Am J Pathol; 2011 Nov; 179(5):2501-18. PubMed ID: 21924229
[TBL] [Abstract][Full Text] [Related]
47. A Myogenic Double-Reporter Human Pluripotent Stem Cell Line Allows Prospective Isolation of Skeletal Muscle Progenitors.
Wu J; Matthias N; Lo J; Ortiz-Vitali JL; Shieh AW; Wang SH; Darabi R
Cell Rep; 2018 Nov; 25(7):1966-1981.e4. PubMed ID: 30428361
[TBL] [Abstract][Full Text] [Related]
48. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction.
Alexakis C; Partridge T; Bou-Gharios G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C661-9. PubMed ID: 17475662
[TBL] [Abstract][Full Text] [Related]
49. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
Nishiyama T; Takeda S
Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
[TBL] [Abstract][Full Text] [Related]
50. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
[TBL] [Abstract][Full Text] [Related]
51. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.
Sohn J; Lu A; Tang Y; Wang B; Huard J
Hum Mol Genet; 2015 Jul; 24(13):3814-29. PubMed ID: 25859011
[TBL] [Abstract][Full Text] [Related]
52. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
53. [Derivation of engraftable myogenic precursors from murine ES/iPS cells and generation of disease-specific iPS cells from patients with Duchenne muscular dystrophy (DMD) and other diseases].
Nakahata T; Awaya T; Chang H; Mizuno Y; Niwa A; Fukada S; Takeda S; Yamanaka S; Heike T
Rinsho Shinkeigaku; 2010 Nov; 50(11):889. PubMed ID: 21921492
[No Abstract] [Full Text] [Related]
54. Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells.
Shoji E; Woltjen K; Sakurai H
Methods Mol Biol; 2016; 1353():89-99. PubMed ID: 25971915
[TBL] [Abstract][Full Text] [Related]
55. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
56. Interplay between Pitx2 and Pax7 temporally governs specification of extraocular muscle stem cells.
Kuriki M; Korb A; Comai G; Tajbakhsh S
PLoS Genet; 2024 Jun; 20(6):e1010935. PubMed ID: 38875306
[TBL] [Abstract][Full Text] [Related]
57. Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy.
Filareto A; Darabi R; Perlingeiro RC
J Stem Cell Res Ther; 2012 Jan; 10(1):. PubMed ID: 23483458
[TBL] [Abstract][Full Text] [Related]
58. Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle.
Tsao J; Vernet DA; Gelfand R; Kovanecz I; Nolazco G; Bruhn KW; Gonzalez-Cadavid NF
Stem Cell Res Ther; 2013 Jan; 4(1):4. PubMed ID: 23295128
[TBL] [Abstract][Full Text] [Related]
59. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.
De Bari C; Dell'Accio F; Vandenabeele F; Vermeesch JR; Raymackers JM; Luyten FP
J Cell Biol; 2003 Mar; 160(6):909-18. PubMed ID: 12629053
[TBL] [Abstract][Full Text] [Related]
60. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy.
Péault B; Rudnicki M; Torrente Y; Cossu G; Tremblay JP; Partridge T; Gussoni E; Kunkel LM; Huard J
Mol Ther; 2007 May; 15(5):867-77. PubMed ID: 17387336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
